| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.0069 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |